Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNA‐421 inhibition alleviates bronchopulmonary dysplasia in a mouse model via targeting Fgf10

29 May 2019

Abstract excerpt

Bronchopulmonary dysplasia (BPD) is a common and refractory disease affecting newborn children and infants with alveolar dysplasia and declined pulmonary function. Several microRNAs (miRNAs) have been found to be differentially expressed in BPD progression. This study further explores the role of miR-421 via fibroblast growth factor 10 (Fgf10) in mice with BPD. A mouse model of BPD was established through the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Congenital Anomalies and Fetal Surgery
Share to Congenital Diaphragmatic Hernia Studies
Share to Neonatal Respiratory Health Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31144392
DOI: 10.1002/jcb.28945

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNA‐421 inhibition alleviates bronchopulmonary dysplasia in a mouse model via targeting Fgf10PMID 31144392Read ↗

miRNA Signatures in Bronchopulmonary Dysplasia: Implications for Biomarkers, Pathogenesis, and Therapeutic OptionsSemantic proximity Read ↗

Deficiency of SPP1 alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal miceSemantic proximity Read ↗

Bronchopulmonary dysplasia: A review of pathogenesis and pathophysiology.Semantic proximity Read ↗

Recent Advances in Bronchopulmonary Dysplasia: Pathophysiology, Prevention, and Treatment.Semantic proximity Read ↗

Nesfatin-1 Suppresses Inflammation in Bronchopulmonary Dysplasia by Regulating HMGB-1/TLR4/p65/NLRP3 Signaling PathwaySemantic proximity Read ↗

Inhibition of microRNA-29a alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice via upregulation of GAB1Semantic proximity Read ↗

MicroRNA Expression Profile in Hyperoxia-Exposed Newborn Mice During the Development of Bronchopulmonary DysplasiaSemantic proximity Read ↗

Bronchopulmonary Dysplasia: Pathogenesis and PathophysiologySemantic proximity Read ↗

Pathogenesis of bronchopulmonary dysplasia.Semantic proximity Read ↗

Bronchopulmonary Dysplasia: Pathogenesis and PathophysiologySemantic proximity Read ↗

SIRT1-Related Signaling Pathways and Their Association With Bronchopulmonary DysplasiaSemantic proximity Read ↗

Fgf10 deficiency is causative for lethality in a mouse model of bronchopulmonary dysplasiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.